Jun Kawashima Selected Research

Jun Kawashima Research Topics

13	Primary Myelofibrosis (Myelosclerosis) 02/2024 - 01/2017
6	Anemia 02/2024 - 01/2020
4	Thrombocytopenia (Thrombopenia) 11/2023 - 02/2018
3	Fatigue 11/2023 - 01/2017
2	Neoplasms (Cancer) 01/2024 - 11/2023
2	Inflammation (Inflammations) 01/2024 - 01/2020
2	Pneumonia (Pneumonitis) 09/2023 - 01/2023
2	Splenomegaly 01/2023 - 01/2020
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 11/2018
2	Essential Thrombocythemia 01/2017 - 01/2017
2	Polycythemia Vera 01/2017 - 01/2017
1	Thrombosis (Thrombus) 01/2024
1	Asthenia 09/2023
1	Enteritis 09/2023
1	Colic (Abdominal Cramps) 07/2023
1	Colonic Neoplasms (Colon Cancer) 07/2023
1	Wounds and Injuries (Trauma) 06/2023
1	Thrombocytopenia 4 01/2023
1	Acute Kidney Injury (Acute Renal Failure) 01/2023
1	Diarrhea 01/2022
1	Fever (Fevers) 01/2022
1	Neutropenia 01/2022
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2022
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2020
1	Obesity 01/2020
1	Thoracic Aortic Aneurysm 06/2019
1	Spinal Cord Injuries (Spinal Cord Injury) 06/2019
1	Sarcoma (Soft Tissue Sarcoma) 11/2018
1	Adenocarcinoma of Lung 02/2018
1	Abdominal Pain (Pain, Abdominal) 02/2018
1	Peripheral Nervous System Diseases (PNS Diseases) 02/2018
1	Heart Arrest (Cardiac Arrest) 02/2018
1	Sepsis (Septicemia) 02/2018
1	Respiratory Insufficiency (Respiratory Failure) 02/2018
1	Hemorrhage 02/2018
1	Sleepiness 01/2017
1	Headache (Headaches) 01/2017
1	Dizziness (Lightheadedness) 01/2017
1	Nausea 01/2017
1	Dyspnea (Shortness of Breath) 01/2017

15	N- (cyanomethyl)- 4- (2- ((4- (4- morpholinyl)phenyl)amino)- 4- pyrimidinyl)benzamideIBA 02/2024 - 01/2017
6	Janus Kinase InhibitorsIBA 02/2024 - 02/2018
5	Janus KinasesIBA 11/2023 - 02/2018
4	ruxolitinibIBA 02/2024 - 02/2018
4	Danazol (Azol)FDA LinkGeneric 11/2023 - 01/2023
4	Janus Kinase 1IBA 11/2023 - 01/2017
4	activin AIBA 11/2023 - 01/2023
2	IronIBA 01/2023 - 01/2020
1	Biomarkers (Surrogate Marker)IBA 02/2024
1	Carcinoembryonic AntigenIBA 01/2024
1	Protein CIBA 01/2024
1	ErbB Receptors (EGF Receptor)IBA 01/2022
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2022
1	Tyrosine Kinase InhibitorsIBA 01/2022
1	Interleukin-6 (Interleukin 6)IBA 01/2022
1	CytokinesIBA 01/2022
1	axicabtagene ciloleucelIBA 01/2022
1	PolymersIBA 01/2020
1	Dietary Fiber FDA Link 01/2020
1	paramylonIBA 01/2020
1	HepcidinsIBA 01/2020
1	PlatinumIBA 11/2018
1	trametinibIBA 11/2018
1	Alanine Transaminase (SGPT)IBA 11/2018
1	Janus Kinase 2IBA 01/2017

5	Therapeutics 02/2024 - 02/2018
1	Perioperative Period 01/2024
1	Lymph Node Excision (Lymph Node Dissection) 07/2023
1	Colectomy 07/2023
1	Negative-Pressure Wound Therapy 06/2023
1	Stents 06/2019
1	Sutures (Suture) 06/2019
1	Drug Therapy (Chemotherapy) 11/2018
1	Erythrocyte Transfusion 02/2018
1	Drug Tapering 02/2018